Is Amneal Pharmaceuticals, Inc. (AMRX) a Buy, Sell, or Hold?
NASDAQ : AMRX
Amneal Pharmaceuticals, Inc. — Analyst Ratings
$18.46 USD
-$0.02 (-0.11%)
- Volume
- 1.76M
- Average Volume
- 1.92M
- Market Capitalization
- $5.89B
- P/E Ratio
- 37.11
- Dividend Yield
- 0.00%
- Price Target
- $19.00
- Year High
- $19.26
- Year Low
- $7.98
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $2.20
Analyst Consensus Summary
Consensus Rating
Neutral
17 Analysts
Rating Score
3/5
Recommendation Strength
Upside/Downside
-2.8%
vs Current Price
Price Target
$19.00
Average TargetPrice Target Range
Lowest Target
$16.00
15.4% UPSIDE
Average Target
$19.00
Median Estimate
Highest Target
$25.00
-26.2% DOWNSIDEAnalyst Breakdown
Overall Consensus: Buy | Total Analysts: 17
| Strong Buy | Buy | Hold | Sell | Strong Sell |
|---|---|---|---|---|
| 0 | 11 | 6 | 0 | 0 |
Analyst Ratings (Detailed)
| Analyst Company | Analyst Name | Price Target | Price When Posted | Date | Upside/Downside |
|---|---|---|---|---|---|
| UBS | Ashwani Verma | $23 | $17.095 | 2026-07-15 07:59 AM | 34.5% |
| Barclays | Glen Santangelo | $16 | $11.81 | 2026-05-20 05:13 AM | 35.5% |
| UBS | Ashwani Verma | $19 | $13.09 | 2026-04-17 04:56 AM | 45.1% |
| Truist Financial | Les Sulewski | $17 | $13.453 | 2026-03-02 07:16 AM | 26.4% |
| Piper Sandler | David Amsellem | $11 | $8.29 | 2024-11-11 07:22 AM | 32.7% |